Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Reshape Lifesciences Inc (RSLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 360
  • Shares Outstanding, K 9,010
  • Annual Sales, $ 1,290 K
  • Annual Income, $ -33,820 K
  • 36-Month Beta 1.87
  • Price/Sales 0.28
  • Price/Cash Flow N/A
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -32.95
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -15.89
  • Growth Rate Est. (year over year) +6,386.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.04 +11.43%
on 09/21/18
0.08 -48.68%
on 09/17/18
-0.03 (-44.29%)
since 08/21/18
3-Month
0.04 +11.43%
on 09/21/18
3.20 -98.78%
on 07/10/18
-2.34 (-98.36%)
since 06/21/18
52-Week
0.04 +11.43%
on 09/21/18
39.00 -99.90%
on 10/17/17
-27.71 (-99.86%)
since 09/21/17

Most Recent Stories

More News
ReShape Lifesciences to Present at H.C. Wainwright 20th Annual Global Investment Conference

SAN CLEMENTE, CA / ACCESSWIRE / August 24, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the...

RSLS : 0.04 (unch)
Investor Expectations to Drive Momentum within Plains Group Holdings, EnteroMedics, Vanda Pharmaceuticals, Cinemark, EPR Properties, and The Estee Lauder Companies -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Plains Group Holdings, L.P....

CNK : 38.55 (+0.63%)
EPR : 68.93 (+0.07%)
EL : 143.54 (+0.67%)
VNDA : 20.10 (+0.25%)
RSLS : 0.04 (unch)
PAGP : 24.15 (-0.62%)
Developments in the Obesity Treatment Market

According to Grand View Research, the global obesity treatment market was valued at USD 3.9 billion in 2015 and is expected to reach $15.6 billion by 2024. The demand for weight management continues to...

OBLN : 2.62 (-0.38%)
BICX : 0.1060 (-5.36%)
VVUS : 5.15 (-1.34%)
ZFGN : 10.78 (-1.55%)
RSLS : 0.04 (unch)
Consolidated Research: 2018 Summary Expectations for Envision Healthcare, Taylor Morrison Home, Vertex Pharmaceuticals, ReShape Lifesciences Inc., American Axle & Manufacturing, and Lattice Semiconductor -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Envision Healthcare Corporation...

TMHC : 19.19 (+0.52%)
LSCC : 7.71 (unch)
AXL : 18.54 (-2.11%)
VRTX : 180.08 (-0.24%)
EVHC : 45.66 (-0.22%)
RSLS : 0.04 (unch)
ReShape Lifesciences Announces Agreement with Academy Medical to Provide ReShape Balloon and ReShape vBloc to Department of Defense Facilities

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced an exclusive federal government business channel sales...

RSLS : 0.04 (unch)
Zacks.com highlights: Avon Products, Altria Group, EnteroMedics, Macquarie Infrastructure and Sibanye Gold

Zacks.com highlights: Avon Products, Altria Group, EnteroMedics, Macquarie Infrastructure and Sibanye Gold

SBGL : 2.52 (+0.40%)
MO : 62.55 (+0.47%)
MIC : 46.68 (-0.47%)
AVP : 2.44 (+1.67%)
RSLS : 0.04 (unch)
Rising P/E: An Overlooked Way to Reach 5 Winning Stocks

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

SBGL : 2.52 (+0.40%)
MO : 62.55 (+0.47%)
MIC : 46.68 (-0.47%)
AVP : 2.44 (+1.67%)
RSLS : 0.04 (unch)
ReShape Lifesciences To Host Third Quarter Conference Call On November 14, 2017

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that it will host a conference call to discuss financial...

RSLS : 0.04 (unch)
EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS)

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that the Company has formally changed its name to ReShape Lifesciences...

ETRM : 2.05 (+3.54%)
RSLS : 0.04 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade RSLS with:

Business Summary

ReShape Lifesciences Inc. is a developer of invasive medical devices to treat obesity and metabolic diseases. The company's portfolio includes vBloc System(R), ReShape(R) and Gastric Vest System (TM). ReShape Lifesciences Inc., formerly known as EnteroMedics Inc., is based in CA, United States.

See More

Key Turning Points

2nd Resistance Point 0.05
1st Resistance Point 0.04
Last Price 0.04
1st Support Level 0.03
2nd Support Level 0.03

See More

52-Week High 39.00
Fibonacci 61.8% 24.12
Fibonacci 50% 19.52
Fibonacci 38.2% 14.92
Last Price 0.04
52-Week Low 0.04

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar